RBC Capital analyst Joseph Pepper maintained a Buy rating on Veolia Environnement (0NY8 – Research Report) on January 21 and set a price target ...
RBC Capital analyst Rishi Jaluria maintained a Buy rating on Pegasystems (PEGA – Research Report) on January 20 and set a price target of ...
Onome Gbinije says that before she joined Royal Bank of Canada (RBC), she was only interested in attending business school. But thanks to two RBC early talent programs that provide professional ...
RBC Capital Markets updated its outlook on Compagnie Financiere Richemont SA (JO:CFRJ) (CFR:SW) (OTC: CFRUY), increasing the ...
The Texas utility regulator has given Entergy the green light to spend $137 million to strengthen its portion of the electric grid against extreme weather. Entergy owns the power lines and poles ...
THAT’S TUESDAY AND WEDNESDAY. I COULD EVEN HAVE WIND CHILLS AS LOW A Entergy Louisiana and Entergy New Orleans are prepared to respond to any power outages caused by winter weather this week.
Standard Capital Markets Limited is an India-based non-deposit accepting non-banking financial company (NBFC). The Company provides a range of financial services, which includes lending of money ...
and MXN” RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, National Bank economist Warren Lovely noted the ...
RBC Wealth Management provided insights into several key events that could influence European stock markets in the first quarter of 2025. With various potential developments on the horizon ...
NEW ORLEANS (WVUE) - Entergy New Orleans leadership said it did not expect the city would see widespread outages during the winter weather this week. Vice President of Customer Service and ...
RBC Emerging Markets Equity Fund earns a High Process Pillar rating. The predominant contributor to the rating is its parent firm's superior long-term risk-adjusted performance, as shown by the ...
Andrew D. Dickinson, the Chief Financial Officer of Gilead Sciences, Inc. (NASDAQ:GILD), a prominent biotechnology company with a market capitalization of $113 billion and "GREAT" financial health ...